Reported Reactions

Devices › Laparoscope, general & plastic surgery

Device brand name · Laparoscope general and plastic surgery

Endopath Xcel Trocar: medical device reports filed with FDA

844 reports name it, 2009–2020. Manufacturer given most often on reports: Ethicon Endo-Surgery. Product code GCJ.

844
device reports naming the brand
0% of all MAUDE reports · about 48 a year
0
reports, 12 months to August 2026
0 in the 12 months before
96.3%
classified as malfunction
90.1% across the product code
0.9%
classified as death, as reported
8 reports · not verified by FDA

FDA's MAUDE database holds 844 reports that name the brand "Endopath Xcel Trocar" (laparoscope general and plastic surgery), received between January 2009 and July 2020; the manufacturer given most often on reports is Ethicon Endo-Surgery. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.3%), injury (2.7%) and death (0.9%); across all laparoscope, general & plastic surgery reports (product code GCJ) death is recorded in 0.3% and malfunction in 90.1%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are air leak (38%), leak/splash (21.2%) and gas/air leak (10.8%). The patient problems coded most often are foreign body, removal of, death and no patient involvement. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Endopath Xcel Trocar was received in the five years to August 2026; the latest was received in July 2020.

By year received

03326642009: 5820092011: 66420112012: 3620122013: 720132014: 4820142015: 1720152016: 420162017: 420172019: 320192020: 32020

Event type and report source

Event type, as classified on the report

Death0.9%8
Injury2.7%23
Malfunction96.3%813
Other0%0
Not given0%0

Who filed the report

Manufacturer report99.9%843
Voluntary report0.1%1
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 84,093 reports carrying product code GCJ. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Air leak32138%2.2%
Leak/splashthe device leaked17921.2%3.9%
Gas/air leak9110.8%1.7%
Device operates differently than expectedthe device behaved unexpectedly445.2%1%
Breakthe device broke404.7%13.5%
Mechanical problema mechanical problem394.6%0.9%
Fluid/blood leak293.4%0.6%
Detachment of device component263.1%5.3%
Component falling232.7%1.6%
Noise, audible232.7%0.5%
Ambient noise problem141.7%0%
Inflation problem121.4%4.3%
Decrease in pressure91.1%0.5%
Melted80.9%0.2%
Sticking80.9%3%
Device contamination with chemical or other material70.8%0.3%
Insufficient device problem information70.8%0.6%
Difficult to insertthe device was hard to insert60.7%1.2%
Hole in material60.7%0.2%
Device dislodged or dislocated50.6%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Foreign body, removal of111.3%
Deaththe patient died; cause not stated by this term50.6%
No patient involvement40.5%
Surgical procedure40.5%
Surgical procedure, additional40.5%
Hemorrhage/blood loss/bleeding30.4%
Abscessa collection of pus20.2%
Bleeding20.2%
Internal organ perforation20.2%
Blood loss10.1%
Burn(s)a burn10.1%
Discomfortdiscomfort10.1%
Failure to anastomose10.1%
Foreign body in patientpart of a device left in the patient10.1%
Hematomaa collection of blood under the skin or in tissue10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureEndopath Xcel TrocarProduct code GCJAll MAUDE reports
Reports84484,09326,136,888
Share of that pool—1%0%
Classified as death, per 1,000 reports939
Classified as injury2.7%8.3%36.2%
Classified as malfunction96.3%90.1%62.3%
Filed by the manufacturer99.9%94.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code GCJ

BrandReportsLatest 12 monthsClassified as death
Endoeye Flex Deflectable Videoscope8,0622,2450%
Auto Suture3,1002340.1%
Endopath Dilating Tip Trocar2,47500.4%
VersaOne1,8902510.2%
Endoeye Flex 3d Deflectable Videoscope1,8257110%
Spacemaker1,3791460%
Versaport1,198640.1%
Endopath Disposable Surgical Trocar1,15300.4%
Pdb1,2531800%
Endopath Xcel Bladeless Trocar986280.3%
Auto Suture Multifire Endo Gia 30-2 593300%
Lapro-Clip856540.2%
Auto Suture Endo Clip 5mm79500%
Endopath Xcel786380.5%
Protack801440.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Endopath Xcel Trocar reports

How many FDA reports name Endopath Xcel Trocar?

844 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (96.3%), injury (2.7%) and death (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

air leak (38%), leak/splash (21.2%), gas/air leak (10.8%), device operates differently than expected (5.2%) and break (4.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.9%) and voluntary reports (0.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Endopath Xcel Trocar was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.